Novel Imaging Agent Developed By Penn Researchers Provides Insight Into Brain's Message Delivery System
Researchers at Penn develop groundbreaking new brain tracer Trodat to evaluate brain function in normal and disease states. The imaging agent, derived from tropane, follows the flow of dopamine in the brain and can be used as a diagnostic tool for imaging dopamine transporters.